The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Lamotrigine versus Placebo in the Prophylaxis of Migraine with and Without aura
Abstract
Lamotrigine blocks voltage-sensitive sodium channels, leading to inhibition of neuronal release of glutamate. Release of glutamate may be essential in the propagation of spreading cortical depression, which some believe is central to the genesis of migraine attacks. This study compared safety and efficacy of lamotrigine and placebo in migraine prophylaxis in a double-blind randomized parallel-groups trial. A total of 110 patients entered; after a 1-month placebo run-in period, placebo-responders and non-compliers were excluded, leaving 77 to be treated with lamotrigine ( n=37) or placebo ( n=40) for up to 3 months. Initially lamotrigine therapy was commenced at the full dose of 200 mg/day, but, following a high incidence of skin rashes, a slow dose-escalation was introduced: 25 mg/day for 2 weeks, 50 mg/day for 2 weeks, then 200 mg/day. Attack rates were reduced from baseline means of 3.6 per month on lamotrigine and 4.4 on placebo to 3.2 and 3.0 respectively during the last month of treatment. Improvements were greater on placebo and these changes, not statistically significant, indicate that lamotrigine is ineffective for migraine prophylaxis. There were more adverse events on lamotrigine than on placebo, most commonly rash. With slow dose-escalation their frequency was reduced and the rate of withdrawal for adverse events was similar in both treatment groups.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pathophysiology of the migraine aura: The spreading depression theory
Lauritzen, M. (1994) · Brain · doi:10.1093/brain/117.1.199 · Cited by 1,151
Guidelines for Controlled Trials of Drugs in Migraine: Second Edition
International Headache Society Clinical Trials Subcommittee, Tfelt-Hansen, P., Block, G., Dahlöf, C., Diener, H.-C., Ferrari, M., Goadsby, P., Guidetti, V, Jones, B., Lipton, R., et al. (2000) · Cephalalgia · doi:10.1046/j.1468-2982.2000.00117.x · Cited by 698
Self-citation
Cited by
Silberstein, S. D., Holland, S., Freitag, F., Dodick, D. W., Argoff, C., & Ashman, E. (2012) · Neurology · doi:10.1212/wnl.0b013e3182535d20 · Cited by 897
EFNS guideline on the drug treatment of migraine—revised report of an EFNS task force
Evers, S., Áfra, J., Frese, A., Goadsby, P. J., Linde, M., May, A., & Sándor, P. S. (2009) · European Journal of Neurology · doi:10.1111/j.1468-1331.2009.02748.x · Cited by 892
Pietrobon, D., & Moskowitz, M. A. (2013) · Annual Review of Physiology · doi:10.1146/annurev-physiol-030212-183717 · Cited by 680
Chronic disorders with episodic manifestations: focus on epilepsy and migraine
Haut, S. R., Bigal, M. E., & Lipton, R. B. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70348-9 · Cited by 315
Silberstein, S. D. (2009) · Neurologic Clinics · doi:10.1016/j.ncl.2008.11.007 · Cited by 299
Metadata
- Authors
- Steiner, T., Findley, L., & Yuen, A.
- Venue
- Cephalalgia
- Publisher
- SAGE Publications
- Published
- 1997-04
- Volume
- 17
- Issue
- 2
- Pages
- 109-112
- ISSN
- 0333-1024 (ISSN-L)
- 1468-2982
- OpenAlex
- W1990075674
- Cited by
- 214
- References
- 2
- FWCI
- 3.81
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Lamotrigine versus Placebo in the Prophylaxis of Migraine with and Without aura. https://app.cochat.ai/papers/10.1046/j.1468-2982.1997.1702109.x
- The paper
- Steiner, T., Findley, L., & Yuen, A. (1997). Lamotrigine versus Placebo in the Prophylaxis of Migraine with and Without aura. Cephalalgia. https://doi.org/10.1046/j.1468-2982.1997.1702109.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.